Another study suggests that the expression of T-cell immunoglobulin mucin-3 (TIM-3, also named HAVCR2) and lymphocyte-activation gene-3 (LAG3) in patients with more severe COVID-19 is much higher than that in patients with mild disease. The gene discussed is HAVCR2; the disease is COVID-19.